Table of Contents 1 Study Coverage 1.1 Irritable Bowel Syndrome (IBS) Product 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Product 1.4.2 IBS-D Drug 1.4.3 IBS-C Drug 1.4.4 Other 1.5 Market by End User 1.5.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by End User 1.5.2 Women 1.5.3 Men 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Irritable Bowel Syndrome (IBS) Market Size 2.1.1 Global Irritable Bowel Syndrome (IBS) Revenue 2014-2025 2.1.2 Global Irritable Bowel Syndrome (IBS) Sales 2014-2025 2.2 Irritable Bowel Syndrome (IBS) Growth Rate by Regions 2.2.1 Global Irritable Bowel Syndrome (IBS) Sales by Regions 2.2.2 Global Irritable Bowel Syndrome (IBS) Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Irritable Bowel Syndrome (IBS) Sales by Manufacturers 3.1.1 Irritable Bowel Syndrome (IBS) Sales by Manufacturers 3.1.2 Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturers 3.1.3 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI) 3.2 Irritable Bowel Syndrome (IBS) Revenue by Manufacturers 3.2.1 Irritable Bowel Syndrome (IBS) Revenue by Manufacturers (2014-2019) 3.2.2 Irritable Bowel Syndrome (IBS) Revenue Share by Manufacturers (2014-2019) 3.3 Irritable Bowel Syndrome (IBS) Price by Manufacturers 3.4 Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution, Product Types 3.4.1 Irritable Bowel Syndrome (IBS) Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Irritable Bowel Syndrome (IBS) Product Type 3.4.3 Date of International Manufacturers Enter into Irritable Bowel Syndrome (IBS) Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Product 4.1 Global Irritable Bowel Syndrome (IBS) Sales by Product 4.2 Global Irritable Bowel Syndrome (IBS) Revenue by Product 4.3 Irritable Bowel Syndrome (IBS) Price by Product 5 Breakdown Data by End User 5.1 Overview 5.2 Global Irritable Bowel Syndrome (IBS) Breakdown Data by End User 6 North America 6.1 North America Irritable Bowel Syndrome (IBS) by Countries 6.1.1 North America Irritable Bowel Syndrome (IBS) Sales by Countries 6.1.2 North America Irritable Bowel Syndrome (IBS) Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Irritable Bowel Syndrome (IBS) by Product 6.3 North America Irritable Bowel Syndrome (IBS) by End User 7 Europe 7.1 Europe Irritable Bowel Syndrome (IBS) by Countries 7.1.1 Europe Irritable Bowel Syndrome (IBS) Sales by Countries 7.1.2 Europe Irritable Bowel Syndrome (IBS) Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Irritable Bowel Syndrome (IBS) by Product 7.3 Europe Irritable Bowel Syndrome (IBS) by End User 8 Asia Pacific 8.1 Asia Pacific Irritable Bowel Syndrome (IBS) by Countries 8.1.1 Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Countries 8.1.2 Asia Pacific Irritable Bowel Syndrome (IBS) Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Irritable Bowel Syndrome (IBS) by Product 8.3 Asia Pacific Irritable Bowel Syndrome (IBS) by End User 9 Central & South America 9.1 Central & South America Irritable Bowel Syndrome (IBS) by Countries 9.1.1 Central & South America Irritable Bowel Syndrome (IBS) Sales by Countries 9.1.2 Central & South America Irritable Bowel Syndrome (IBS) Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Irritable Bowel Syndrome (IBS) by Product 9.3 Central & South America Irritable Bowel Syndrome (IBS) by End User 10 Middle East and Africa 10.1 Middle East and Africa Irritable Bowel Syndrome (IBS) by Countries 10.1.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Countries 10.1.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Irritable Bowel Syndrome (IBS) by Product 10.3 Middle East and Africa Irritable Bowel Syndrome (IBS) by End User 11 Company Profiles 11.1 Allergan 11.1.1 Allergan Company Details 11.1.2 Company Business Overview 11.1.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Allergan Irritable Bowel Syndrome (IBS) Products Offered 11.1.5 Allergan Recent Development 11.2 Valeant Pharmaceuticals 11.2.1 Valeant Pharmaceuticals Company Details 11.2.2 Company Business Overview 11.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2014-2019) 11.2.4 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Products Offered 11.2.5 Valeant Pharmaceuticals Recent Development 11.3 Takeda 11.3.1 Takeda Company Details 11.3.2 Company Business Overview 11.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2014-2019) 11.3.4 Takeda Irritable Bowel Syndrome (IBS) Products Offered 11.3.5 Takeda Recent Development 11.4 Sucampo Pharmaceuticals 11.4.1 Sucampo Pharmaceuticals Company Details 11.4.2 Company Business Overview 11.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Products Offered 11.4.5 Sucampo Pharmaceuticals Recent Development 11.5 McNeil Consumer Healthcare 11.5.1 McNeil Consumer Healthcare Company Details 11.5.2 Company Business Overview 11.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2014-2019) 11.5.4 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Products Offered 11.5.5 McNeil Consumer Healthcare Recent Development 11.6 Sebela Pharmaceuticals 11.6.1 Sebela Pharmaceuticals Company Details 11.6.2 Company Business Overview 11.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2014-2019) 11.6.4 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Products Offered 11.6.5 Sebela Pharmaceuticals Recent Development 11.7 Astellas Pharmaceuticals 11.7.1 Astellas Pharmaceuticals Company Details 11.7.2 Company Business Overview 11.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2014-2019) 11.7.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Products Offered 11.7.5 Astellas Pharmaceuticals Recent Development 11.8 IM HealthScience 11.8.1 IM HealthScience Company Details 11.8.2 Company Business Overview 11.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2014-2019) 11.8.4 IM HealthScience Irritable Bowel Syndrome (IBS) Products Offered 11.8.5 IM HealthScience Recent Development 12 Future Forecast 12.1 Irritable Bowel Syndrome (IBS) Market Forecast by Regions 12.1.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Regions 2019-2025 12.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Regions 2019-2025 12.2 Irritable Bowel Syndrome (IBS) Market Forecast by Product 12.2.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Product 2019-2025 12.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Product 2019-2025 12.3 Irritable Bowel Syndrome (IBS) Market Forecast by End User 12.4 North America Irritable Bowel Syndrome (IBS) Forecast 12.5 Europe Irritable Bowel Syndrome (IBS) Forecast 12.6 Asia Pacific Irritable Bowel Syndrome (IBS) Forecast 12.7 Central & South America Irritable Bowel Syndrome (IBS) Forecast 12.8 Middle East and Africa Irritable Bowel Syndrome (IBS) Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Irritable Bowel Syndrome (IBS) Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Irritable Bowel Syndrome (IBS) Product Picture Table Irritable Bowel Syndrome (IBS) Market Segments Table Key Manufacturers Irritable Bowel Syndrome (IBS) Covered Table Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$) Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Product 2014-2025 Figure IBS-D Drug Product Picture Table Major Manufacturers of IBS-D Drug Figure IBS-C Drug Product Picture Table Major Manufacturers of IBS-C Drug Figure Other Product Picture Table Major Manufacturers of Other Table Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by End User 2019-2025 (K Units) Figure Women Figure Men Figure Irritable Bowel Syndrome (IBS) Report Years Considered Figure Global Irritable Bowel Syndrome (IBS) Market Size 2014-2025 (Million US$) Figure Global Irritable Bowel Syndrome (IBS) Sales 2014-2025 (K Units) Table Global Irritable Bowel Syndrome (IBS) Market Size by Regions 2014-2019 (K Units) & (Million US$) Table Global Irritable Bowel Syndrome (IBS) Sales by Regions 2014-2019 (K Units) Table Global Irritable Bowel Syndrome (IBS) Sales Market Share by Regions 2014-2019 Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Regions 2014-2019 Figure 2018 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Regions Table Global Irritable Bowel Syndrome (IBS) Revenue by Regions 2014-2019 (Million US$) Table Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions 2014-2019 Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions 2014-2019 Figure 2018 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions Table Global Irritable Bowel Syndrome (IBS) Sales by Manufacturers (2014-2019) (K Units) Table Global Irritable Bowel Syndrome (IBS) Sales Share by Manufacturers (2014-2019) Figure Global Irritable Bowel Syndrome (IBS) Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Irritable Bowel Syndrome (IBS) Revenue by Manufacturers (2014-2019) (Million USD) Table Irritable Bowel Syndrome (IBS) Revenue Share by Manufacturers (2014-2019) Figure Irritable Bowel Syndrome (IBS) Value Share by Manufacturers in 2018 Table Key Manufacturers Irritable Bowel Syndrome (IBS) Price (2014-2019) (USD/Unit) Table Irritable Bowel Syndrome (IBS) Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Irritable Bowel Syndrome (IBS) Product Type Table Date of International Manufacturers Enter into Irritable Bowel Syndrome (IBS) Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Irritable Bowel Syndrome (IBS) Sales by Product (2014-2019) (K Units) Table Global Irritable Bowel Syndrome (IBS) Sales Share by Product (2014-2019) Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Product (2014-2019) Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Product in 2018 Table Global Irritable Bowel Syndrome (IBS) Revenue by Product (2014-2019) (Million US$) Table Global Irritable Bowel Syndrome (IBS) Revenue Share by Product (2014-2019) Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Product (2014-2019) Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Product in 2018 Table Irritable Bowel Syndrome (IBS) Price by Product 2014-2019 (USD/Unit) Table Global Irritable Bowel Syndrome (IBS) Sales by End User (2014-2019) (K Units) Table Global Irritable Bowel Syndrome (IBS) Sales Share by End User (2014-2019) Figure Global Sales Irritable Bowel Syndrome (IBS) Market Share by End User (2014-2019) Figure Global Sales Irritable Bowel Syndrome (IBS) Market Share by End User in 2018 Figure North America Irritable Bowel Syndrome (IBS) Sales Growth Rate 2014-2019 (K Units) Figure North America Irritable Bowel Syndrome (IBS) Revenue Growth Rate 2014-2019 (Million US$) Table North America Irritable Bowel Syndrome (IBS) Sales by Countries (2014-2019) (K Units) Table North America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2014-2019) Figure 2018 North America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries Table North America Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019) (Million US$) Table North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019) Figure 2018 North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries Figure United States Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure United States Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (K Units) Figure Canada Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Canada Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Mexico Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Table North America Irritable Bowel Syndrome (IBS) Sales by Product (2014-2019) (K Units) Table North America Irritable Bowel Syndrome (IBS) Sales Market Share by Product (2014-2019) Figure 2018 North America Irritable Bowel Syndrome (IBS) Market Share by Product Table North America Irritable Bowel Syndrome (IBS) Sales by End User (2014-2019) (K Units) Table North America Irritable Bowel Syndrome (IBS) Sales Market Share by End User (2014-2019) Figure 2018 North America Irritable Bowel Syndrome (IBS) Market Share by End User Figure Europe Irritable Bowel Syndrome (IBS) Sales Growth Rate 2014-2019 (K Units) Figure Europe Irritable Bowel Syndrome (IBS) Revenue Growth Rate 2014-2019 (Million US$) Table Europe Irritable Bowel Syndrome (IBS) Sales by Countries (2014-2019) (K Units) Table Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2014-2019) Figure 2018 Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Countries Table Europe Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019) (Million US$) Table Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019) Figure 2018 Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries Figure Germany Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Germany Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure France Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure France Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure UK Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure UK Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Italy Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Russia Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Table Europe Irritable Bowel Syndrome (IBS) Sales by Product (2014-2019) (K Units) Table Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Product (2014-2019) Figure 2018 Europe Irritable Bowel Syndrome (IBS) Market Share by Product Table Europe Irritable Bowel Syndrome (IBS) Sales by End User (2014-2019) (K Units) Table Europe Irritable Bowel Syndrome (IBS) Sales Market Share by End User (2014-2019) Figure 2018 Europe Irritable Bowel Syndrome (IBS) Market Share by End User Figure Asia Pacific Irritable Bowel Syndrome (IBS) Sales Growth Rate 2014-2019 (K Units) Figure Asia Pacific Irritable Bowel Syndrome (IBS) Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Countries (2014-2019) (K Units) Table Asia Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Countries Table Asia Pacific Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019) (Million US$) Table Asia Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019) Figure 2018 Asia Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries Figure China Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure China Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Japan Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Korea Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Korea Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure India Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure India Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Australia Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Indonesia Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Malaysia Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Philippines Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Thailand Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Vietnam Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Singapore Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Singapore Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Irritable Bowel Syndrome (IBS) Sales by Product (2014-2019) (K Units) Table Asia Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Product (2014-2019) Figure 2018 Asia Pacific Irritable Bowel Syndrome (IBS) Market Share by Product Table Asia Pacific Irritable Bowel Syndrome (IBS) Sales by End User (2014-2019) (K Units) Table Asia Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by End User (2014-2019) Figure 2018 Asia Pacific Irritable Bowel Syndrome (IBS) Market Share by End User Figure Central & South America Irritable Bowel Syndrome (IBS) Sales Growth Rate 2014-2019 (K Units) Figure Central & South America Irritable Bowel Syndrome (IBS) Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Irritable Bowel Syndrome (IBS) Sales by Countries (2014-2019) (K Units) Table Central & South America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2014-2019) Figure 2018 Central & South America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries Table Central & South America Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019) (Million US$) Table Central & South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019) Figure 2018 Central & South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries Figure Brazil Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Brazil Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Argentina Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Argentina Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Irritable Bowel Syndrome (IBS) Sales by Product (2014-2019) (K Units) Table Central & South America Irritable Bowel Syndrome (IBS) Sales Market Share by Product (2014-2019) Figure 2018 Central & South America Irritable Bowel Syndrome (IBS) Market Share by Product Table Central & South America Irritable Bowel Syndrome (IBS) Sales by End User (2014-2019) (K Units) Table Central & South America Irritable Bowel Syndrome (IBS) Sales Market Share by End User (2014-2019) Figure 2018 Central & South America Irritable Bowel Syndrome (IBS) Market Share by End User Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Growth Rate 2014-2019 (K Units) Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Countries (2014-2019) (K Units) Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Countries Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Countries (2014-2019) (Million US$) Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2014-2019) Figure 2018 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries Figure GCC Countries Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure GCC Countries Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Turkey Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Turkey Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure Egypt Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Irritable Bowel Syndrome (IBS) Sales Growth Rate (2014-2019) (K Units) Figure South Africa Irritable Bowel Syndrome (IBS) Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Product (2014-2019) (K Units) Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Product (2014-2019) Figure 2018 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Share by Product Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by End User (2014-2019) (K Units) Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by End User (2014-2019) Figure 2018 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Share by End User Table Allergan Company Details Table Allergan Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Allergan Recent Development Table Valeant Pharmaceuticals Company Details Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Valeant Pharmaceuticals Recent Development Table Takeda Company Details Table Takeda Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Takeda Recent Development Table Sucampo Pharmaceuticals Company Details Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Sucampo Pharmaceuticals Recent Development Table McNeil Consumer Healthcare Company Details Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table McNeil Consumer Healthcare Recent Development Table Sebela Pharmaceuticals Company Details Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Sebela Pharmaceuticals Recent Development Table Astellas Pharmaceuticals Company Details Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table Astellas Pharmaceuticals Recent Development Table IM HealthScience Company Details Table IM HealthScience Irritable Bowel Syndrome (IBS) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019) Table IM HealthScience Recent Development Table Global Irritable Bowel Syndrome (IBS) Sales Forecast by Regions 2019-2025 (K Units) Table Global Irritable Bowel Syndrome (IBS) Sales Market Share Forecast by Regions 2019-2025 Table Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Irritable Bowel Syndrome (IBS) Revenue Market Share Forecast by Regions 2019-2025 Table Global Irritable Bowel Syndrome (IBS) Sales Forecast by Product 2019-2025 (K Units) Table Global Irritable Bowel Syndrome (IBS) Sales Market Share Forecast by Product 2019-2025 Table Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Product 2019-2025 (Million US$) Table Global Irritable Bowel Syndrome (IBS) Revenue Market Share Forecast by Product 2019-2025 Table Global Irritable Bowel Syndrome (IBS) Sales Forecast by End User 2019-2025 (K Units) Table Global Irritable Bowel Syndrome (IBS) Sales Market Share Forecast by End User 2019-2025 Figure North America Irritable Bowel Syndrome (IBS) Sales Growth Rate Forecast (2019-2025) (K Units) Figure North America Irritable Bowel Syndrome (IBS) Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Irritable Bowel Syndrome (IBS) Sales Growth Rate Forecast (2019-2025) (K Units) Figure Europe Irritable Bowel Syndrome (IBS) Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Irritable Bowel Syndrome (IBS) Sales Growth Rate Forecast (2019-2025) (K Units) Figure Asia Pacific Irritable Bowel Syndrome (IBS) Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Irritable Bowel Syndrome (IBS) Sales Growth Rate Forecast (2019-2025) (K Units) Figure Central & South America Irritable Bowel Syndrome (IBS) Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Growth Rate Forecast (2019-2025) (K Units) Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Irritable Bowel Syndrome (IBS) Value Chain Table Irritable Bowel Syndrome (IBS) Customers List Table Irritable Bowel Syndrome (IBS) Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Allergan Valeant Pharmaceuticals Takeda Sucampo Pharmaceuticals McNeil Consumer Healthcare Sebela Pharmaceuticals Astellas Pharmaceuticals IM HealthScience